CHICAGO (November 18, 2020)—Blipcare, the company that developed the world's first Wi-Fi blood pressure monitor, announced availability of its new cellular blood pressure monitor, the Blip BP800. The Blip BP800 is specifically designed to serve patients who need Remote Patient Monitoring (RPM). It requires neither setup nor cables to plug in. The monitor is the only product of its kind on the market that supports multiple users - and even guest users.

NETANYA, Israel (November 18, 2020)—Eitan Group announced that, as of Nov.16, 2020, it has rebranded, consolidating its product lines under the new Eitan Medical brand. Eitan Medical is a global provider of advanced infusion therapy solutions across the care continuum.
 

CAESAREA, Israel (November 17, 2020)—Itamar Medical Ltd., a medical device and digital health company leading the integration of sleep apnea management into the cardiac patient care pathway, today announced the preliminary results from two large claims database studies that demonstrated the significant health economic benefits of effective sleep apnea management for patients with chronic cardiovascular diseases.

ATLANTA (November 17, 2020)—Medtrade Account Executive York Schwab will take on the role of show director for the nation’s largest home medical equipment-focused trade show, replacing Mark Lind. “Mark was a huge part of our team who taught me a lot,” Schwab says, “and he will certainly be missed.”

AMSTERDAM (November 17, 2020)—Royal Philips, a global provider of health technology, today announced findings from its first ever World COPD Day survey ahead of the awareness day on November 18. Philips surveyed more than 4,000 adults in China, India, Russia and the U.S. to gather insights on global awareness of respiratory conditions, such as chronic obstructive pulmonary disease (COPD), and how the COVID-19 pandemic has influenced overall perceptions of respiratory health.

WASHINGTON, D.C. (November 13, 2020)—The Centers for Medicare & Medicaid Services (CMS) announced that Medicare beneficiaries can receive coverage of monoclonal antibodies to treat coronavirus disease 2019 (COVID-19) with no cost-sharing during the public health emergency (PHE). CMS’s coverage of monoclonal antibody infusions applies to bamlanivimab, which received an emergency use authorization (EUA) from the U.S. Food and Drug Administration on Nov. 9.

FRISCO, Texas (November 13, 2020)—Addus HomeCare Corporation, a provider of homecare services, has announced the signing of a definitive agreement to acquire Queen City Hospice, LLC, and its affiliate Miracle City Hospice, LLC (together Queen City Hospice) for a cash purchase price of $192.0 million, representing $162.8 million of value, net of the present value of $29.2 million in estimated tax benefits.